Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. dr. Leander Van Neste

No current affiliation with UGent

Show Sort by

Add to list
- Journal Article
- A1
- open access
Evaluation of an epigenetic assay for predicting repeat prostate biopsy outcome in African American men

Robert L, Jr Waterhouse, Leander Van Neste (UGent) , Kelvin A Moses, Carlton Barnswell, Jonathan L Silberstein, Mark Jalkut, Ronald Tutrone, James Sylora, Ronald Anglade, Myron Murdock, et al.

(2019) UROLOGY. 128. p.62-65
Add to list
A four-gene promoter methylation marker panel consisting of GREM1, NEURL, LAD1, and NEFH predicts survival of clear cell renal cell cancer patients

Iris JH van Vlodrop, Sophie C Joosten, Tim De Meyer (UGent) , Kim M Smits, Leander Van Neste (UGent) , Veerle Melotte, Marcella MLL Baldewijns, Leo J Schouten, Piet A van den Brandt, Jana Jeschke, et al.

(2017) CLINICAL CANCER RESEARCH. 23(8). p.2006-2018
Add to list
- Conference Paper
- C3
Evaluation of different methods to assess homologous recombination status and sensitivity to PARP inhibitors in ovarian cancer

A Mukhopadhyay, M Dixon, E Mulligan, H Schuhwerk, J Murray, J Quinn, Leander Van Neste (UGent) , Wim Van Criekinge (UGent) , N Curtin and R Edmondson

(2014) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 24(9, suppl. 4). p.353-354
Add to list
CD44 and OTP are strong prognostic markers for pulmonary carcinoids

Dorian RA Swarts, Mieke ER Henfling, Leander Van Neste (UGent) , Robert Jan van Suylen, Anne-Marie C Dingemans, Winand NM Dinjens, Annick Haesevoets, Martina Rudelius, Erik Thunnissen, Marco Volante, et al.

(2013) CLINICAL CANCER RESEARCH. 19(8). p.2197-2207
Add to list
Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study

Grant D Stewart, Leander Van Neste (UGent) , Philippe Delvenne, Paul Delrée, Agnès Delga, S Alan McNeill, Marie O'Donnell, James Clark, Wim Van Criekinge (UGent) , Joseph Bigley, et al.

(2013) JOURNAL OF UROLOGY. 189(3). p.1110-1116
Add to list
Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen

Jana Jeschke, Leander Van Neste (UGent) , Sabine C Glöckner, Mashaal Dhir, Marilia Freitas Calmon, Valerie Deregowski, Wim Van Criekinge (UGent) , Ilse Vlassenbroeck, Alexander Koch (UGent) , Timothy A Chan, et al.

(2012) EPIGENETICS. 7(7). p.701-709
Add to list
- Journal Article
- A1
- open access
A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection

Leander Van Neste (UGent) , Joseph Bigley, Adam Toll, Gaëtan Otto, James Clark, Paul Delrée, Wim Van Criekinge (UGent) and Jonathan I Epstein

(2012) BMC UROLOGY. 12.
Add to list
The epigenetic promise for prostate cancer diagnosis.

Leander Van Neste (UGent) , James G Herman, Gaëtan Otto, Joseph W Bigley, Jonathan I Epstein and Wim Van Criekinge (UGent)

(2012) PROSTATE. 72(11). p.1248-1261
Add to list
- Conference Paper
- C3
Genome‐wide RNA‐ and MBD‐sequencing in HCT116 and DKO cells as a global re‐expression model

Joachim De Schrijver (UGent) , Geert Trooskens (UGent) , Linda JW Bosch, Pierre Dehan, Beatriz Carvalho, Leander Van Neste (UGent) , Gerrit Meijer, Steve Baylin and Wim Van Criekinge (UGent)

(2012) Intelligent Systems for Molecular Biology, 20th Annual international conference, Abstracts.
Add to list
Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells

Joyce E Ohm, Prashant Mali, Leander Van Neste (UGent) , David M Berman, Liang Liang, Kurinji Pandiyan, Kimberley J Briggs, Wei Zhang, Pedram Argani, Brian Simons, et al.

(2010) CANCER RESEARCH. 70(19). p.7662-7673

1
2
3

Next →